We envision a world where patients with cancer receive an effective drug the first time. About 30% of patients have mutations in their DNA that indicate they'll respond well to certain drugs; we develop drugs for the other 70%. We combined our drug, NMI-900, with a unique diagnostic that measures RNA rather than DNA. Our approach has the potential to select the right patient, improve survival, and limit side effects. In 5 years, we look forward to regulatory approval in AML and helping patients.
Find out more at:
https://wefunder.com/nemucore.medical.innovations.inc
Company Details
- Employees
- 4
- Founded
- -
- Address
- One Hollis Street, Wellesley,ma 02482,united States
- Phone
- (508)471-4647
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nemucore.com
- HQ
- Wellesley, MA
Nemucore Medical Innovations, Inc. Questions
Nemucore Medical Innovations, Inc.'s helpline number is (508)471-4647
Nemucore Medical Innovations, Inc.'s website is nemucore.com
Nemucore Medical Innovations, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nemucore
Nemucore Medical Innovations, Inc. has
4 employees.
View email and phone details for 4
employees at Nemucore Medical Innovations, Inc..
Nemucore Medical Innovations, Inc.'s industry is
Biotechnology Research
Nemucore Medical Innovations, Inc.'s top competitors are
Mzeal,
Pioneer Valley Life Sciences Institute,
Pharmask,
Niviron Inc.,
One Biotech Inc,
Outlier Biopharma,
Quartet Medicine,
Paredox Therapeutics Llc,
Paros Bio,
Oriel Research Therapeutics (Ort).
Nemucore Medical Innovations, Inc.'s categories are Biotechnology Research
Nemucore Medical Innovations, Inc.'s founding year is 2008
